As the world continues to recover from the impact of the global COVID-19 pandemic, a new investment fund has been launched to accelerate access to modern medical care for those most in need.
The Abdul Latif Jameel Investment Management Company (JIMCO) is a new venture investment business consolidating the work of three generations in purposeful investing from one of the Middle East’s most renowned and respected privately owned diversified family businesses and global philanthropies.
The JIMCO Life Sciences Fund, one of three major fund silos, has been established specifically to invest in innovation for a healthier world.
Working closing with Abdul Latif Jameel Health in realizing the ambition of accelerating access to healthcare for those who need it most, the JIMCO Life Sciences Fund invests in the future of health-tech, thoughtfully selecting both venture fund investments and pioneering early stage businesses.
Together, they are focused on delivering real-world tangible solutions to meet the rising health demand for modern medical care and drive great global health inclusivity, particularly for the ‘global south’.